ArticleCancer management and research2021

Effect of Regorafenib in Delaying Definitive Deterioration in Health-Related Quality of Life in Patients with Advanced Cancer of Three Different Tumor Types.

Ralf-Dieter Hofheinz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.